BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth
Titel:
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth
Auteur:
Yasui, Hiroshi Hideshima, Teru Ikeda, Hiroshi Jin, Janice Ocio, Enrique M. Kiziltepe, Tanyel Okawa, Yutaka Vallet, Sonia Podar, Klaus Ishitsuka, Kenji Richardson, Paul G. Pargellis, Chris Moss, Neil Raje, Noopur Anderson, Kenneth C.